AzTrials
AzTrials

Attention Deficit Hyerpactivity DisorderPhase 2/3NCT07836972

Novel Approaches to Supporting Students With ADHD in Multi-Tiered Systems of Support

A Phase 2/3 study testing Academic Competency Enhancement (ACE) classroom and School as Usual Classroom Supports in people with Attention Deficit Hyerpactivity Disorder, run by Florida International University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Children with attention-deficit/hyperactivity disorder (ADHD) are likely to exhibit behavioral difficulties in the classroom that inhibit learning (Daley \& Birchwood, 2010; DuPaul \& Stoner, 2003; Fabiano et al., 2006; Friedman \& Pfiffner, 2020; Loe \& Feldman, 2007; Raggi \& Chronis, 2006; Rapport, Chung, Shore, \&… Read more about this study

Who is it for?
Ages 4 to 12 years
Conditions the study is for
Attention Deficit Hyerpactivity Disorder
What is being tested?
Academic Competency Enhancement (ACE) classroom and School as Usual Classroom Supports
Could I receive a placebo?
No, everyone receives an active treatment
How many people
544 participants
Where
No sites listed yet
Study dates
1 Jan 2027to 31 Aug 2031
Phase
Phase 2/3
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Elevated ADHD symptoms and impairment and referred to school-based support team for intervention.
  • Attending grades kindergarten - fifth

Who cannot join

  • Special education classification for academics or behavior
  • Behavior concerns at a level that would make lead-in treatment inappropriate/of insufficient intensity

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Gregory A. Fabiano, Ph.D. contact

716-359-7823

gfabiano@fiu.edu

About this study

Official title: Novel Approaches to Supporting Students With ADHD in Multi-Tiered Systems of Support (MTSS)

Children with attention-deficit/hyperactivity disorder (ADHD) are likely to exhibit behavioral difficulties in the classroom that inhibit learning (Daley \& Birchwood, 2010; DuPaul \& Stoner, 2003; Fabiano et al., 2006; Friedman \& Pfiffner, 2020; Loe \& Feldman, 2007; Raggi \& Chronis, 2006; Rapport, Chung, Shore, \& Isaacs, 2001). These issues make addressing ADHD an area in need of continuous and contemporary support, particularly during early elementary school (Bitsko et al., 2022), in order to prevent the worsening, life-long issues that individuals with ADHD may confront throughout the lifespan. The present application focuses on supports and interventions for students in elementary school, as that is where initial identification and intervention typically occurs (Visser et al., 2014). With the advent of Multi-Tiered Systems of Support (MTSS) within school settings, a systematic approach to the delivery of universal, targeted, and indicated school mental health and educational supports may be enhanced. The most intensive tier of the MTSS (i.e., Tier 3) is currently the most under-developed. The creation of a positive behavioral support classroom through Tier 3 of the MTSS will assist teachers in improving the positive behavioral support provided to the student with ADHD. Thus, the present investigation will be situated within everyday school procedures for supporting a student with behaviors consistent with ADHD. Participants will be 288 elementary school children recruited from participating school districts within the existing school-based problem solving teams. We will work with grades kindergarten to sixth. Referred children will then all receive a lead-in, Tier 2 intervention to include a daily report card (DRC) intervention. Those who continue to need additional behavior supports in the Spring -- Tier 3 intervention -- will be allocated through random assignment to School as Usual or Academic/Behavior Competency (ACE) classroom in a Hybrid Type 1 design. The ACE classroom is an approach based on decades of research in summer treatment program classrooms (Fabiano et al., 2007; Pelham et al., 2025). Aim 1 evaluates the outcomes of the approach relative to school as usual. Aim 2 evaluates the implementation of the approach and explores components of user implementation that promote fidelity. Aim 3 explores moderators of the intervention outcomes (e.g., comorbid oppositional/aggressive behavior or learning disabilities).

Being tested
Academic Competency Enhancement (ACE) classroom, School as Usual Classroom Supports
Keywords
ADHD, school intervention, positive behavior support
Medical subject headings
Attention Deficit Disorder with Hyperactivity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Academic Competency Enhancement (ACE) classroomBehavioural

    Children assigned to ACE will enroll in a classroom with a teacher trained to implement contingency management components throughout the school year.

  • School as Usual Classroom SupportsBehavioural

    This arm will include school as usual procedures for students.

Study groups in NCT07836972
Study groupRoleWhat they receive
School as UsualActive comparatorLead-in Intervention followed by Assignment to School as Usual
Receives: Behavioral: School as Usual Classroom Supports
Academic Competency Enhancement (ACE) classroomExperimentalLead-in Intervention followed by Assignment to Academic Competency Enhancement (ACE) classroom
Receives: Behavioral: Academic Competency Enhancement (ACE) classroom

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Count of Child rule violations

    Observation of frequency of rule violations

    Measured: Baseline, End of School year 1, Beginning of School year 2, Middle of School year 2, End of School year 2

  2. IOWA Connors Rating Scale

    Total Score on Inattentive/Overactive Factor

    Measured: Baseline, End of School year 1, Beginning of School year 2, Middle of School year 2, End of School year 2

  3. Impairment Rating Scale

    Measured: Baseline, End of School year 1, Beginning of School year 2, Middle of School year 2, End of School year 2

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Sep 2026
  2. Study start1 Jan 2027 (estimated)
  3. Primary completion31 Aug 2030 (estimated)
  4. Study completion31 Aug 2031 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
All participants will receive a lead-in positive behavior support intervention; those who exhibit continued impairment will be randomly assigned to the intervention classroom or school as usual.
Masking
None (open label)
Enrolment
544 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07836972
Sponsor's protocol ID
R01MH144202
Status last verified
Sep 2026
First submitted
17 Sep 2026
Last updated
28 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing Academic Competency Enhancement (ACE) classroom and School as Usual Classroom Supports in people with Attention Deficit Hyerpactivity Disorder, run by Florida International University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 28 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Gregory A. Fabiano, Ph.D. (716-359-7823, gfabiano@fiu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Count of Child rule violations (time frame: Baseline, End of School year 1, Beginning of School year 2, Middle of School year 2, End of School year 2). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in